Navigation Links
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Announces FDA Filings for Paliperidone Palmitate and INVEGA(R)
Date:2/6/2009

TITUSVILLE, N.J., Feb. 6 /PRNewswire/ -- Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD) today announced that the company has submitted multiple applications to the U.S. Food and Drug Administration (FDA) which, if approved, would broaden treatment options for patients diagnosed with schizophrenia or schizoaffective disorder.

Earlier this week, the company submitted its response to the FDA complete response letter for paliperidone palmitate, received in August 2008. Paliperidone palmitate is an investigational once-monthly atypical antipsychotic injection which, if approved, will be indicated for the acute and maintenance treatment of schizophrenia.

The company also submitted two supplemental new drug applications (sNDAs) to the FDA requesting approval for the use of INVEGA tablets for the treatment of schizoaffective disorder as monotherapy and for use in combination with antidepressants and/or mood stabilizers. The sNDA submissions include data from two international, 6-week double-blind placebo-controlled studies that evaluated the efficacy and safety of INVEGA in patients with schizoaffective disorder. If approved by the FDA, INVEGA would be the only medication indicated to treat the condition.

Patients with schizoaffective disorder experience the psychotic symptoms of schizophrenia, such as hallucinations or delusions, as well as mania and/or depression. Because of the similarity in symptoms, schizoaffective disorder is sometimes misdiagnosed as schizophrenia or bipolar disorder. For patients who frequently use mental health services, schizophrenia and schizoaffective disorder may account for approximately 32% and 24% of cases respectively.(i)

INVEGA, an atypical antipsychotic medication, was first approved in the U.S. in December 2006 and is marketed by Janssen. It is approved for the acute and maintenance treatment of schizophrenia in the U.S. an
'/>"/>

SOURCE Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD)
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Johnson & Johnson to Provide Webcast Presentation of Tapentadol Phase 3 Clinical Data Presented at American Pain Societys Annual Meeting
2. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
3. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
4. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
5. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
8. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
9. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
10. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... May 05, 2015 Research and Markets ... "Home Healthcare Global Market - Forecast to 2020" ... healthcare market is expected to reach more than $300+ ... The home healthcare equipment market is expected to ... services market. Home healthcare is gaining a tremendous attention ...
(Date:5/5/2015)... Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ) ... for the three months ended March 31, 2015 compared ... million for the same period in 2014.  Isis, significantly ... milestone payments earned from its partners compared to the ... reported a loss from operations of $9.3 million for ...
(Date:5/5/2015)... May 5, 2015 Big Market Research presents ... Europe , ( France , ... Spain , UK) and Japan . Current ... The report provides the 5-year test volume and sales forecasts by ... Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT ...
Breaking Medicine Technology:Global Home Healthcare Global Market 2015 - Forecast to 2020 for the $300 Billion Market 2Isis Reports Financial Results and Highlights for First Quarter 2015 2Isis Reports Financial Results and Highlights for First Quarter 2015 3Isis Reports Financial Results and Highlights for First Quarter 2015 4Isis Reports Financial Results and Highlights for First Quarter 2015 5Isis Reports Financial Results and Highlights for First Quarter 2015 6Isis Reports Financial Results and Highlights for First Quarter 2015 7Isis Reports Financial Results and Highlights for First Quarter 2015 8Isis Reports Financial Results and Highlights for First Quarter 2015 9Isis Reports Financial Results and Highlights for First Quarter 2015 10Isis Reports Financial Results and Highlights for First Quarter 2015 11Isis Reports Financial Results and Highlights for First Quarter 2015 12Isis Reports Financial Results and Highlights for First Quarter 2015 132015 Opportunities in the Global Hepatitis Diagnostic Testing Market: Big Market Research 22015 Opportunities in the Global Hepatitis Diagnostic Testing Market: Big Market Research 3
... Pa., Oct. 27, 2011 ViroPharma Incorporated (NASDAQ: ... has signed a definitive agreement to acquire DuoCort ... Sweden focused on improving glucocorticoid replacement therapy.  The ... ViroPharma,s orphan disease commercial product pipeline.  The company ...
... Oct. 27, 2011 ViroPharma Incorporated (Nasdaq: VPHM ) ... 30, 2011. In the third quarter of 2011, we: ... representing 21 percent growth over the third quarter of 2010; ... quarter and $184 million for the 9 month period,  representing Cinryze ...
Cached Medicine Technology:ViroPharma to Acquire DuoCort Pharma AB, Adding Important European Orphan Drug to Commercial Pipeline 2ViroPharma to Acquire DuoCort Pharma AB, Adding Important European Orphan Drug to Commercial Pipeline 3ViroPharma to Acquire DuoCort Pharma AB, Adding Important European Orphan Drug to Commercial Pipeline 4ViroPharma to Acquire DuoCort Pharma AB, Adding Important European Orphan Drug to Commercial Pipeline 5ViroPharma to Acquire DuoCort Pharma AB, Adding Important European Orphan Drug to Commercial Pipeline 6ViroPharma to Acquire DuoCort Pharma AB, Adding Important European Orphan Drug to Commercial Pipeline 7ViroPharma Incorporated Reports Third Quarter 2011 Financial Results 2ViroPharma Incorporated Reports Third Quarter 2011 Financial Results 3ViroPharma Incorporated Reports Third Quarter 2011 Financial Results 4ViroPharma Incorporated Reports Third Quarter 2011 Financial Results 5ViroPharma Incorporated Reports Third Quarter 2011 Financial Results 6ViroPharma Incorporated Reports Third Quarter 2011 Financial Results 7ViroPharma Incorporated Reports Third Quarter 2011 Financial Results 8ViroPharma Incorporated Reports Third Quarter 2011 Financial Results 9ViroPharma Incorporated Reports Third Quarter 2011 Financial Results 10ViroPharma Incorporated Reports Third Quarter 2011 Financial Results 11ViroPharma Incorporated Reports Third Quarter 2011 Financial Results 12
(Date:5/5/2015)... The newly minted Regan Arts has just released a unique self-help ... from his 20 years working in the field of wilderness therapy. ... a parenting book and why this one, she replied, “What resonates ... it is a journey, not a destination...that the question is not ... together and sometimes not...that each of our struggles is unique. What ...
(Date:5/5/2015)... Georgia (PRWEB) May 05, 2015 ... of Victoria BC announced the Skedans Sensor Collaboration ... platform, for mobile and web app developers, provides tooling ... airborne and mobile sensors. , The Skedans Sensor Collaboration ... the intersection of the Internet of Things, Web Real ...
(Date:5/5/2015)... Information Innovators Inc. (“Triple-i”), ... government, today announced its acquisition of Creative ... exclusively to federal government customers through its highly ... health services, and program management support. The company ... a Third Party Assessment Organization (3PAO) for cloud ...
(Date:5/5/2015)... 05, 2015 On May, 5, 2015, My ... musician Irene Rose about alternatives for youngsters to do this ... you get the idea for starting a summer camp and ... an entertainment company called Once Upon a Party and I ... through songs and even scripture. We play games, sing, and ...
(Date:5/5/2015)... 05, 2015 RF Technologies®, a leading ... Sensatec® ST750 Fall Management Solution with Voice Alarms. The ... patient or resident to wait for assistance when it ... the choice of 16 different melodies or tones or ... system such as Code Alert®. , For 28 ...
Breaking Medicine News(10 mins):Health News:The Last Parenting Book You Will Ever Need: Veteran Publisher Judith Regan Releases A Provocative New Book By Dr. Brad Reedy, "The Journey Of The Heroic Parent" 2Health News:The Last Parenting Book You Will Ever Need: Veteran Publisher Judith Regan Releases A Provocative New Book By Dr. Brad Reedy, "The Journey Of The Heroic Parent" 3Health News:Skedans Systems Announces Skedans Sensor Collaboration Platform at AUVSI's Unmanned Systems 2015 in Atlanta 2Health News:Information Innovators Inc. (Triple-i) Acquires Leading Cyber Security and Health-Focused Solutions Company, Creative Computing Solutions, Inc. 2Health News:Information Innovators Inc. (Triple-i) Acquires Leading Cyber Security and Health-Focused Solutions Company, Creative Computing Solutions, Inc. 3Health News:Information Innovators Inc. (Triple-i) Acquires Leading Cyber Security and Health-Focused Solutions Company, Creative Computing Solutions, Inc. 4Health News:My Positive Perspective Hosts Episode Informing People of a True Princess Summer Camp With Irene Rose 2Health News:RF Technologies® Releases Sensatec® ST750 Voice Alarm for Fall Management 2Health News:RF Technologies® Releases Sensatec® ST750 Voice Alarm for Fall Management 3
... reports 8% increase in,surgical procedures, NEW YORK, ... nonsurgical procedures were performed in the United,States in ... American,Society for Aesthetic Plastic Surgery. The Aesthetic Society, ... says the,overall number of cosmetic procedures has increased ...
... Acuo Technologies, a market,leading provider of comprehensive software ... and migration services, announces,record growth during Fiscal Year ... year in sales bookings, while adding 89 additional,implementations ... implementations worldwide., "I am very pleased to ...
... RELEASE , Easing concerns about pollution ... Technology , In a finding that could help ease ... cells, scientists report that the manufacture of solar cells ... technologies. Their report, the first comprehensive study on the ...
... Services to ... Healthcare Market, ORLANDO, Fla., ... ) today unveiled a new family of high-tech,tools that provide clinicians ... in operating room environments and other,healthcare situations. The Harris systems are ...
... CINCINNATI, Feb. 25 LCA-Vision Inc. (Nasdaq:,LCAV), a leading ... announced the opening of a LasikPlus vision center in ... in the United,States and the first LasikPlus vision center ... located in 33 states, serving 58 markets., Similar ...
... ... record, ... and Hill-Rom, an operating company of Hillenbrand Industries,(NYSE: HB ), ... technologies to improve and coordinate healthcare,delivery, featuring Hill-Rom intelligent hospital beds ...
Cached Medicine News:Health News:11.7 Million Cosmetic Procedures in 2007 2Health News:11.7 Million Cosmetic Procedures in 2007 3Health News:11.7 Million Cosmetic Procedures in 2007 4Health News:Acuo Technologies(R) Announces Record Sales and Implementation Growth 2Health News:American Chemical Society's Weekly PressPac -- Feb. 20, 2008 2Health News:American Chemical Society's Weekly PressPac -- Feb. 20, 2008 3Health News:American Chemical Society's Weekly PressPac -- Feb. 20, 2008 4Health News:American Chemical Society's Weekly PressPac -- Feb. 20, 2008 5Health News:American Chemical Society's Weekly PressPac -- Feb. 20, 2008 6Health News:American Chemical Society's Weekly PressPac -- Feb. 20, 2008 7Health News:American Chemical Society's Weekly PressPac -- Feb. 20, 2008 8Health News:American Chemical Society's Weekly PressPac -- Feb. 20, 2008 9Health News:Harris Corporation Unveils Broadcast-Style Multiviewers for Real-Time Multi- Screen Access to Medical Information 2Health News:Harris Corporation Unveils Broadcast-Style Multiviewers for Real-Time Multi- Screen Access to Medical Information 3Health News:LCA-Vision Announces the Opening of its 74th LasikPlus Vision Center in Des Moines, Iowa 2Health News:Cerner Corporation and Hill-Rom Partner to Unify Hospital Care Delivery 2Health News:Cerner Corporation and Hill-Rom Partner to Unify Hospital Care Delivery 3Health News:Cerner Corporation and Hill-Rom Partner to Unify Hospital Care Delivery 4Health News:Cerner Corporation and Hill-Rom Partner to Unify Hospital Care Delivery 5Health News:Cerner Corporation and Hill-Rom Partner to Unify Hospital Care Delivery 6
The Tag-It™ Cystic Fibrosis ASR reagents can be used by high complexity CLIA approved laboratories for detection of up to 70 mutations and 6 variants (polymorphisms) in the cystic fibrosis tran...
... is a wearable CPAP (Continuous Positive Airway ... apnea. The lightweight BreatheX CPAP device (patent ... its built-in, rechargeable battery, and is mobile, ... longer need to be "plugged in to ...
Paraffin Block Storage System...
Shandon Paraffin Block Cabinet...
Medicine Products: